Who would have thought that Menarini decided end of last year to make > 20 years of biotech experience and know-how available to all external customers? Are you an early-stage or more advanced biotech that aims to go from bench to clinic with your antibody candidate? Menarini Biotech has been the CoE for biotech within the Menarini Group in Italy to now focus on making IND-enabling servcies around antibodies, fusion protein, bispecifics, Ab fragments and more, being your CMC partner. In Pisa, your linker, payload, and bioconjugate can be synthesised under GMP at OEL5. In Berlin, your DP can be filled, released ubnder GMP, labelled, and packaged to be send to your next clinical trial site. Still intrigued? Happy to share more in a personal conversation.